Market Cap : 50.01 M | Enterprise Value : 60.54 M | PE Ratio : At Loss | PB Ratio : 2.67 |
---|
AMEX:EMAN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
AMEX:EMAN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
eMagin's other operating expense for the three months ended in Mar. 2022 was $0.00 Mil. Its other operating expense for the trailing twelve months (TTM) ended in Mar. 2022 was $-0.00 Mil.
eMagin's quarterly other operating expense declined from Sep. 2021 ($0.00 Mil) to Dec. 2021 ($-0.00 Mil) but then increased from Dec. 2021 ($-0.00 Mil) to Mar. 2022 ($0.00 Mil).
eMagin's annual other operating expense increased from Dec. 2019 ($-0.00 Mil) to Dec. 2020 ($0.00 Mil) but then stayed the same from Dec. 2020 ($0.00 Mil) to Dec. 2021 ($0.00 Mil).
The historical data trend for eMagin's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expenses" section.
Other operating expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of other operating expenses which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of eMagin's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.
Cronson Paul C | director | C/O LARKSPUR CORP 445 PARK AVE NEW YORK NY 10022 |
Wittels Jill | director | 3006 NORTHUP WAY #103 BELLEVUE WA 98004 |
Richstone Ellen B | director | C/O SONUS NETWORKS, INC. 7 TECHNOLOGY PARK DRIVE WESTFORD MA 01886 |
Seay Stephen | director | 10500 N.E. 8TH STREET, SUITE 1400 BELLEVUE WA 98004 |
Sculley Andrew George Jr | officer: President/CEO | 260 BRIAR DRIVE MARTINEZ CA 94553 |
Braddom Eric | director | C/O EMAGIN CORPORATION 2070 ROUTE 52 BLDG 334 HOPEWELL JUNCTION NY 12533 |
Koch Mark A | officer: CFO | C/O DEL GLOBAL TECHNOLOGIES CORP. ONE COMMERCE PARK VALHALLA NY 10595 |
Awm Investment Company, Inc. | 10 percent owner | 527 MADISON AVENUE SUITE 2600 NEW YORK NY 10022 |
Brody Christopher Scott | director | STILLWATER LLC 655 MADISON AVE NEW YORK NY 10065 |
Costello Stephen | officer: S V P Strategic Partnerships | C/O EMAGIN CORPORATION 2070 ROUTE 52 BUILDING 334 HOPEWELL JUNCTION NY 12533 |
Polgar Leslie G | director | 3006 NORTHUP WAY SUITE 103 BELLEVUE WA 98004 |
Saltarelli Joseph | other: Sr. VP of Manufacturing | C/O EMAGIN CORPORATION 2070 ROUTE 52 BLDG 334 HOPEWELL JUNCTION NY 12533 |
Lucas Jeffrey P | officer: Chief Financial Officer | C/O EMAGIN CORP. 2070 ROUTE 52 HOPEWELL JUNCTION NY 12533 |
Ghosh Amalkumar | officer: Sr. VP, R&D | 2070 ROUTE 52 HOPEWELL JUNCTION NY 12533 |
Olivier Prache | officer: Sr. VP Product Development | 213 MANVILLE ROAD PLEASANTVILLE NY 10570 |
Other Sources
By Zacks 2020-11-24
By Zacks 2021-08-12
By Zacks 2020-08-31
By Seekingalpha 2020-11-12
By Zacks 2020-11-19
By Zacks 2020-09-04
By Seekingalpha 2022-03-10
By Seekingalpha 2020-12-04
By Zacks 2020-06-15
By Zacks 2021-11-04
By Seekingalpha 2020-08-13
By Seekingalpha 2021-11-12
By Seekingalpha 2021-03-18